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Abstract  
Adult Long-Evans female rats sustained electrolytic fimbria-fornix lesions and, two weeks later, received intrahippocampal suspension 
grafts of fetal septal tissue. Sham-operated and lesion-only rats served as controls. Between 6.5 and 8 months after grafting, both the 
[3H]choline accumulation and the electrically evoked [3H]acetylcholine ([3H]ACh) release were assessed in hippocampal s ices. The 
release of [3H]ACh was measured in presence of atropine (muscarinic antagonist, 1 /xM), physostigmine (acetylcholinesterase inhibitor, 
0.1 /.tM), oxotremorine (muscarinic agonist, 0.01 /xM-10 p.M), mecamylamine (nicotinic antagonist, 10 ~M), methiothepin (mixed 
5-HT1/5-HT 2 antagonist, 10 /zM), 8-OH-DPAT (5-HTIA agonist, 1 /zM), 2-methyl-serotonin (5-HT 3 agonist, 1 /zM) and CP 93129 
(5-HT1B agonist, 0.1 /zM-100 /xM), or without any drug application as a control. In lesion-only rats, the specific accumulation of 
[3H]choline was reduced to 46% of normal and the release of [3H]ACh to 32% (nCi) and 43% (% of tissue tritium content). In the grafted 
rats, these parameters were significantly increased to 63%, 98% and 116% of control, respectively. Physostigmine r duced the evoked 
[3H]ACh release and was significantly more effective in grafted ( -70%)  than in sham-operated ( -56%)  or lesion-only ( -54%)  rats. 
When physostigmine was superfused throughout, mecamylamine had no effect. Conversely, atropine induced a significant increase of 
[3H]ACh release in all groups, but this increase was significantly larger in sham-operated rats (+209%) than in the other groups 
(lesioned: +80%; grafted: + 117%). Oxotremorine dose-dependently decreased the [3H]ACh release, but in lesion-only rats, this effect 
was significantly lower than in sham-operated rats. Whatever group was considered, 8-OH-DPAT, methiothepin and 2-methyl-serotonin 
failed to induce any significant effect on [3H]ACh release. In contrast, CP 93129 dose-dependently decreased [3H]ACh release. This 
effect was significantly weaker in grafted rats than in the rats of the two other groups. Our data confirm that cholinergic terminals in the 
intact hippocampus possess inhibitory muscarinic autoreceptors and serotonin heteroreceptors f the 5-HT1B subtype. They also show that 
both types of receptors are still operative in the cholinergic terminals which survived the lesions and in the grafted cholinergic neurons. 
However, the muscarinic receptors in both lesioned and grafted rats, as well as the 5-HT1B receptors in grafted rats show a sensitivity 
which seems to be downregulated in comparison to that found in sham-operated rats. In the grafted rats, both types of downregulations 
might contribute to (or reflect) an increased cholinergic function that results from a reduction of the inhibitory tonus which ACh and 
serotonin exert at the level of the cholinergic terminal. 
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I .  In t roduct ion  
Partial or extensive lesions of the septo-hippocampal 
pathways are considered as one of the possible experimen- 
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tal models of Alzheimer's disease in animals (e.g., [19,26]). 
Such lesions are known to induce a series of deficits 
including perturbations of the electrophysiological harac- 
teristics of normal hippocampal functioning (e.g., rhythmi- 
cal slow wave activity and place fields; [8,48]), severe and 
lasting depletions of some hippocampal neurotransmitters 
and related enzymes or metabolites (e.g., ,acetylcholine 
(ACh), acetylcholinesterase (ACHE), choline acetyltrans- 
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fe rase  (CHAT)  ac t iv i ty ,  seroton in ;  
[13,14,18,22,27,29,30,52]), as well as dramatic impair- 
ments of learning and memory processes in which the 
hippocampus plays a major role (e.g., [11,20,21,34,43]). 
Some of these lesion-induced disturbances can be attenu- 
ated or even compensated for by intrahippocampal grafts 
rich in fetal cholinergic neurons [19]. The mechanisms by 
which these grafts exert functional effects can be multiple. 
As regards the possible compensation for depleted neuro- 
transmitter systems in a given brain structure of the recipi- 
ent, these mechanisms may involve (i) acute or chronic 
release of growth-promoting and/or neurotrophic factors, 
(ii) diffuse 'minipump-like' delivery of neurotransmitters 
into the brain parenchyma and/or the ventricles, and (iii) 
target-directed release of neurotransmitters within specific 
newly established synaptic ontacts between grafted neu- 
rons and neurons located in the host structure (e.g., [4,10]). 
Do these newly established synapses between the grafted 
neurons and the neurons of the recipient show normal 
functional characteristics? Several studies have contributed 
to progress towards a better understanding of the neurobio- 
logical substrates by which the grafted neurons may be 
functionally integrated into the host neural circuitry. Using 
a microdialysis technique, Nilsson et al. [41,42] have 
shown that basal forebrain grafts placed into the dener- 
vated hippocampus were able to release ACh. A major 
finding was the demonstration that these grafted choliner- 
gic neurons were regulated by host afferents: in their 
grafted rats, both a sensory stimulation (stroking the fur 
and tail) and an electrical activation of the habenula were 
able to markedly increase the hippocampal ACh released 
by the grafted cells, an effect which was also observed in 
virtually intact rats but not in fimbria-fornix lesioned ones. 
More recently, Leanza et al. [33] showed this host-derived 
regulation of grafted neurons to involve catecholaminergic 
afferents from the host: in fimbria-fornix lesioned rats that 
sustained grafts rich in cholinergic neurons, a systemic 
apomorphine (2.0 mg/kg) or amphetamine (2.5 mg/kg) 
treatment increased ACh release to about 190% and 300% 
of baseline, respectively. All these findings strongly sug- 
gest that the activity of fetal cholinergic neurons implanted 
into the denervated hippocampus can be regulated by the 
host brain. 
Beside the mechanisms involving afferences from other 
neurons, the release of a neurotransmitter by a given 
population of neurons is also subject o regulations involv- 
ing presynaptic autoreceptors or heteroreceptors (e.g., [50]). 
Concerning the hippocampal cholinergic afferents in intact 
rats, it is known that evoked ACh release can be decreased 
subsequently to activation of either muscarinic autorecep- 
tors or serotonergic heteroreceptors. In the rat, these het- 
eroreceptors seem to belong to the 5-HT m subtype (e.g., 
[6,7,39]). A few data on other brain regions and species, 
some of them using in vivo techniques, uggest that 5-HT~A 
receptors [3,25,55] and 5-HT 3 receptors [2,15,37] might 
also be involved in the modulation of ACh release, al- 
though contradictory findings have been reported for 5-HT 3 
receptors [28]. 
Our present study was aimed at investigating whether 
the release of ACh by cholinergic neurons grafted into the 
denervated hippocampus of rats is regulated normally by 
muscarinic autoreceptors and serotonergic heteroreceptors. 
Sham-operated and lesion-only rats were used as controls. 
Using hippocampal slices preincubated with [3H]choline 
and subsequently placed into superfusion chambers, the 
electrically-evoked release of [3H]ACh was measured in 
the presence of muscarinic agonists (oxotremorine and, 
acting indirectly, physostigmine) and antagonists (atropine), 
or of drugs affecting 5-HT receptors, i.e. the non selective 
5-HT1/5-HT 2 antagonist methiothepin, the 5-HT1A agonist 
8-OH-DPAT, the 5-HT 3 agonist 2-methyl-serotonin, and 
the selective 5-HT1B agonist CP 93129. Unfortunately, no 
selective 5-HTl~ antagonist is available at present [36]. 
The release measured without any drug application was 
used as the control condition. ACh release was also exam- 
ined in the presence of a nicotinic antagonist, mecamy- 
lamine, as Potter and Nitta [45] have reported that after an 
AF64A-induced cholinergic hippocampal denervation, the 
inhibitory muscarinic receptors located on the spared 
cholinergic terminals were no longer operative, whereas 
facilitatory nicotinic receptors till worked. As additional 
controls for the effects of either the lesions or the grafts, 
we also assessed ChAT activity, noradrenaline (NA), sero- 
tonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) 
concentrations, aswell as the levels of [3H]choline accu- 
mulated by hippocampal s ices during the incubation. 
2. Materials and methods 
2.1. Mater ia ls  
Chemicals and drugs were obtained from the following 
sources: [methyl-3H]choline chloride (69-86 Ci/mmol) 
and [1-14 C]-Acetyl-coenzyme A (60 mCi/mmol) from 
Amersham Buchler, Braunschweig, Germany; atropine sul- 
fate, hemicholinium-3, and oxotremorine sesquifumarate 
from Sigma, Miinchen, Germany; (_+)-8-hydroxy-dipro- 
pylaminotetratin HBr (8-OH-DPAT), mecamylamine HC1, 
methiothepin mesylate, 2-methyl-5-hydroxytryptamine 
maleate (2-methyl-5-HT), and ritanserin from RBI (Bio- 
trend), KiSln, Germany. Finally, 3-(1,2,5,6-tetrahydropyrid- 
4-yl)pyrrolo[3,2-b]pyrid-5-one (CP 93129) was kindly do- 
nated by Dr. Schwegler, Pfizer GmbH, Karlsruhe, Ger- 
many. 
2.2. Subjects  
The study used 42 Long-Evans female rats obtained 
from R. Janvier (France). They were housed in Makrolon 
cages (59 × 38 X 20 cm) in groups of five or six. For 
lesion and transplantation surgeries, they were isolated in 
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smaller cages (42 × 26 × 15 cm) where they were kept for 
3 days after surgery. Food and water were available ad 
libitum. The colony room was maintained on a 12:12 h 
light/dark cycle (lights on at 07.00) under controlled 
temperature (23 + l°C). All procedures involving animals 
and their care were conducted in conformity with the 
institutional guidelines that are in compliance with national 
and international aws and policies (council directive 
#87848, october 19, 1987, Minist~re de l'Agriculture et 
de la ForOt, Service Vdtdrinaire de la Sant£ et de la 
Protection Animales; permission #6212 to J.-C.C.) 
2.3. Surgery 
All surgery was performed under aseptic conditions, 
using equithesin anaesthesia (3 ml/kg, i.p.). 
2.3.1. Lesion surgery 
At 91 (_+ l) days of age, 29 rats received a bilateral 
electrolytic lesion of the infracallosal septo-hippocampal 
pathways (fimbria-fornix). This operation was performed 
by passing a rectified current of 1 mA for 40 s through an 
epoxylite coated stainless-steel ectrode (0.15 mm in di- 
ameter) which was uninsulated at the tip (approx. 0.5 mm). 
The electrode was lowered into the brain at five sites 
according to the following coordinates: from Lambda [44], 
A = 5.2 mm, L = + 0.8 mm, V = -3 .3  mm; A = 5.5 mm, 
L= 0.0 mm, V = -3 .5  mm; A = 5.8 mm, L = _+ 1.8 mm, 
V = - 3.8 mm. The incisor bar was placed 3.0 mm below 
the interaural line. The control group (Group 'Sham'; 
n = 13) consisted of rats which received scalp incision and 
removal of the bone overlying the dorsal parietal cortex. 
2.3.2. Transplant surgery 
Cells to be grafted were prepared from the brains of 
Long-Evans fetuses (CRL: 14 mm; E: 15 days). Two 
weeks after lesion surgery, a subgroup of lesioned rats 
(Group 'Graft'; n = 13) received bilateral intrahippocam- 
pal grafts of a cell suspension prepared from the region 
including the septal-diagonal band of Broca, a region rich 
in cholinergic neurons. The other subgroup of rats (Group 
'Lesion'; n = 16) consisted of lesioned rats which did not 
receive grafts. 
The grafts were performed as described by Cassel et al. 
[12]. Briefly, after extraction of the fetal brains, the ventral 
forebrain region containing the septal area was dissected 
out under a stereoscopic magnifier using sterile instru- 
ments and glassware. The dissection procedure of the fetal 
ventral forebrain was similar to that described by Bj6rklund 
et al. [5]. The tissue fragments were collected in 0.6% 
glucose-saline, incubated for 20 min at 37°C in the same 
solution with 0.1% trypsin (Sigma, Grade II), washed three 
times with 5 ml of fresh glucose-saline and brought o a 
final volume of about 10 /xl per septal tissue. These blocks 
were then dissociated using a fire-polished Pasteur pipette 
until obtention of a milky suspension. Injections (2/M/site, 
1 /zl/min) of the resulting suspension were performed 
stereotaxically, through a Hamilton syringe, into each dor- 
sal hippocampus atthe following coordinates: from Lambda 
[44], A = 4.0 ram, L = + 1.5 ram, V = 3.1 ram; A = 3.0 
mm, L= __+2.5 mm, V = 3.3 mm. The incisor bar was 
placed 3.0 mm below the interaural line. The syringe was 
left in situ for 2 min after each injection. Cell suspensions 
were used within a maximum of 3 h after preparation. The 
number of cells injected was counted in a haemocytometer 
(Thoma chamber, for details see [12]) and non-viable cells 
were identified with 0.05% Trypan blue. Counts of cells 
per /M were 52,500, with about 5% damaged, non-viable, 
cells. 
2.4. Accumulation of [3H]choline and evoked release of 
[3H]ACh 
2.4.1. Dissection of the hippocampus 
Between 6.5 and 8 months post-grafting, the rats (Sham, 
n = 11; Lesion, n = 13; Grafted, n = 11) were decapitated 
and their brains were quickly removed. Each brain was 
sectioned transversally immediately before the dorsal edge 
of the hippocampus in order to separate a rostral and a 
caudal brain piece. The rostral piece was collected in 0.1 
M phosphate-buffered 1.6% paraformaldehyde and kept at 
4°C until it was sectioned for determination of the lesion 
extent (see below). From the caudal piece of the brain, 
both hippocampi were dissected free and cut such as to 
separate a portion including the two septal thirds of the 
hippocampus. The most dorsal thirds of the remaining 
ventral parts were homogenized and used for measure- 
ments of neurochemical parameters as described below. 
2.4.2. Superfusion experiments 
The dorsal portion was cut into 350 /xm thick transver- 
sal slices. Starting at the septal pole, the first three slices 
were discarded and the next 14 slices from each hippocam- 
pus were transferred into a small Petri dish containing 2 ml 
Krebs-Henseleit (KH) buffer with [3H]choline (0.1 /zM) 
and incubated for 45 min at 37°C under carbogen. The KH 
solution had the following composition (in mM): NaC1, 
118; KC1, 4.8; CaCI2, 1.3; MgSO4, 1.2; NaHCO3, 25; 
KHzPO4, 1.2; glucose, 11; ascorbic acid, 0.57; Na2EDTA, 
0.03; saturated with carbogen, pH adjusted to 7.4. After 
incubation, 24 slices were transferred into superfusion 
chambers (12 chambers per superfusion apparatus, 1 slice 
per chamber) and superfused with oxygenated KH buffer 
(37°C) at a rate of 0.6 ml/min. The superfusion medium 
was supplemented routinely with hemicholinium-3 (10 
/zM). In addition, either physostigmine (0.1 /~M) was 
present throughout superfusion in experiments assessing 
the effects of cholinergic antagonists (atropine, mecamy- 
lamine), or ritanserin (1 /zM) in experiments investigating 
the effects of serotonergic drugs (agonists and antagonists). 
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An electrical field stimulation (rectangular, 18 pulses, 3 
Hz, 4 V/chamber, 24 mA) was applied 20 min after 
beginning of the superfusion. The collection of 4-min 
fractions was started 25 min later. [3H]ACh release was 
induced by electrical field stimulations (360 rectangular 
pulses at 3 Hz, 4 V/chamber, 24 mA) after 57 min (S 1) 
and 89 rain (S 2) of superfusion. In experiments using 3 
stimulations, the third one (S 3) was applied after 121 min 
of superfusion. At the end of the experiment (after 141 min 
of superfusion), the radioactivity of superfusate samples 
and slices (dissolved in 500 p,l Soluene 350, Packard, 
Frankfurt, Germany) was determined by liquid scintillation 
counting. Calculation of both the spontaneous outflow and 
the stimulation-evoked overflow of tritium was done as 
described previously [24]. 
2.4.3. Application of drugs 
For each rat, the evoked release of [3H]ACh was mea- 
sured after application of different pharmacological sub- 
stances (both cholinergic and serotonergic, as indicated in 
the legends to Figures) and their effects were compared to 
the appropriate control ratios ($2 /S  1 or $3/S ~) without 
drugs. All drugs were added to the superfusion medium 
from 16 min before the corresponding electrical stimula- 
tion (S 2 or S 3) onwards. 
2.4.4. Determination of specific [3 H] choline accumulation 
From the slices which were not used for the release 
experiments, four slices per rat were processed in order to 
determine the proportion of specific [3H]choline accumula- 
tion (i.e., the hemicholinium-3-sensitive fraction of 
[3H]choline accumulated in the cholinergic terminals). The 
slices were incubated using the same conditions as for the 
superfusion experiments, but two of them were incubated 
in the presence of hemicholinium-3 (10 /~M) in order to 
block the high affinity choline uptake into cholinergic 
nerve terminals. Following incubation, all four slices were 
superfused uring 45 min (at a rate of 0.6 ml /min in the 
presence of hemicholinium-3, 10 /zM) without any electri- 
cal field stimulation. Finally, they were solubilized in 500 
/zl 0.1 N NaOH before liquid scintillation counting. For 
each rat, the specific accumulation of [3H]choline was 
expressed as a percentage calculated from the difference 
between the accumulation found in absence and that found 
in presence of hemicholinium-3. The average percentage 
found in each group was taken into consideration for 
correcting the [3H] accumulation of the slices from the 
superfusion experiments with drugs and field-stimulations 
(Fig. 2). 
2.5. Determination of ChAT acticity and HPLC measure- 
ments 
The most dorsal thirds of the remaining ventral parts of 
the hippocampi of the rats were used for determination of
ChAT activity and HPLC measurements. They were col- 
lected in 2 ml of 0.32 M sucrose solution (in 2.5 mM 
HEPES, pH 7.4) and homogenized in a Potter/Elvehjem 
glass/teflon homogenizer (8 strokes at 500 rpm). From 
this crude homogenate, a 20 /xl sample was used for 
determination of protein content, another 100 /xl sample 
for measurements of ChAT activity and a further 700 /zl 
aliquot was mixed with 700 /~1 0.2 N HC104 (containing 
250 mg NazSO 3 and 200 mg disodium EDTA per liter) 
and stored at -20°C for HPLC determinations. 
ChAT activity was determined as described by Fonnum 
[23] with the modifications described previously [14]. The 
concentrations of noradrenaline, 5-HT and 5-HIAA were 
determined by HPLC with electrochemical detection as 
described previously [14], but using an electrochemical 
detector (ECD 460) and pump (model 510) from Waters. 
Protein content was assessed according to the method 
described by Lowry et al. [35]. 
2.6. Histological/histochemical verifications 
Two sham-operated, three lesioned and two grafted rats 
not used in the aforementioned series of experiments were 
anaesthetized with an overdose of pentobarbital (100 
mg/kg,  i.p.) and transcardially perfused with 50 ml of 
0.9% saline followed by 60 ml of 0.1 M phosphate-buffered 
4% paraformaldehyde (4°C). After extraction, the brains 
were post-fixed for about 4 h and transferred into a 0.1 M 
phosphate-buffered 20% sucrose solution for 36-40 h. The 
brains were then quickly frozen and cut into 30 /xm thick 
coronal sections using a cryostat ( -  20°C). From the poste- 
rior septum to the posterior egion of the hippocampus, 
each fifth section was collected onto gelatine-coated slides. 
The sections were dried at room temperature for 36 hours 
and stained either with cresyl violet [49] or for acetyl- 
cholinesterase according to a method similar to that of 
Koelle [31]: ethopropazine (0.3 mM) was used to block 
non-specific holinesterases and acetylthiocholine iodide 
(4 mM) was used as the substrate. 
2.7. Statistical analysis 
As regards [3H]choline accumulation, the individual 
values were obtained from at least 22 slices per rat. The 
amount of 3H release evoked by $1 was calculated for 
each rat using 11 slices per rat. In each other single 
superfusion experiment on hippocampal slices, the data 
from at least 3 slices per drug and concentration conditions 
were averaged for each rat. These average values (originat- 
ing from at least five rats per surgical treatment) were 
analysed by an analysis of variance (ANOVA [56]) fol- 
lowed, where appropriate, by 2 × 2 comparisons based on 
the Duncan's multiple range test [51]. The ANOVA always 
considered the factor 'Group' and, where appropriate, the 
factors 'Drug' or 'Dose'. 
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3. Results 
3.1. Extent of  the lesion, distribution of  AChE staining, 
ChAT activity and levels of noradrenaline, 5-HT and 
5 -HIA4 
The lesions of the fimbria-fornix pathways were compa- 
rable to the lesions performed in previous experiments 
[26,27]. A typical example of such a lesion is shown in 
Fig. 1. Briefly, the lesions damaged the dorsal fornix as 
well as a major part of the fimbria. In only a few rats was 
the most ventral part of the lateral fimbria found to be 
almost intact. These lesions also slightly encroached onto 
the most dorsal portion of the lateral septum, the medial 
part of the overlying corpus callosum and onto the most 
anterior pole of the dorsal hippocampus. As illustrated in 
Fig. 1, the fimbria-fornix lesions induced a dramatic reduc- 
tion of the hippocampal AChE-staining. The grafts con- 
sisted Of well delineated, small cell aggregates which were 
densely AChE-posit ive and which had provided the dener- 
vated hippocampus with an organotypic AChE-posit ive 
reinnervation. They were located within the dentate gyrus 
(Fig. 1E) or close to region CA1 (Fig. IF). 
The lesion-induced cholinergic denervation of the hip- 
pocampus was also confirmed by the ChAT activity data. 
ANOVA of the data showed a significant overall Group 
effect (F (2 ,29)= 9.12, P< 0.001). In the homogenate 
prepared from more ventral parts of the hippocampus (a 
region not used in the superfusion experiments), the le- 
sions had significantly reduced the ChAT activity to 43% 
(+5.1%)  of the control values (sham-operated rats; P < 
0.05). In the grafted rats, the average ChAT activity 
reached 53% (+4.8%)  of the controls (Table 1); this 
reduction was also significant as compared to the sham-op- 
erated rats (P  < 0.05). There was no significant difference 
between the lesioned and the grafted rats. 
Lesion- and graft-induced effects were also studied by 
measuring tissue concentrations of 5-HT, its main metabo- 
lite 5-hydroxyindoleacetic acid (5-HIAA) and noradrena- 
line (NA). ANOVA of 5-HT concentrations showed a 
significant Group effect (F(2,32) = 4.88, P < 0.05) which 
was due to reduced 5-HT concentration i  both lesioned 
Fig. 1. B: photograph s owing the extent of a representative fimbria-fornix lesion on a coronal section (stained for ACHE) located about 1.3 mm posterior 
to Bregma [44]; compare to the intact fimbria-fornix na sham-operated rat (A). AChE-positivity ina coronal section through the dorsal hippocampus of a 
sham-operated (C), a lesioned (D) and two grafted rats, one with a graft located within the dentate gyrus (E), the other one with a graft located partly 
within and partly above area CA1 (F). The arrows point onto the grafted tissue. White (A, B) and black (C-F) scale bars = 500 /.tm. 
158 J.-C. Cassel et al. / Brain Research 704 (1995) 153-166 
Table 1 
Neurochemical measurements in a portion of the ventral hippocampus (next to the part used for superfusion experiments) of sham-operated, lesioned and 
grafted rats 
Parameter measured Sham Lesioned Grafted 
ChAT activity (nmol /mg protein/rain) 0.58 + 0.07 (10) 0.25 +_ 0.04 * (11) 0.31 _+ 0.05 * (11) 
Noradrenaline (ng /mg protein) 2.57 + 0.26 (11) 3.59 + 0.65 (13) 2.59 + 0.37 (11) 
5-HT (ng /mg protein) 2.25 _+ 0.38 (11) 1.01 + 0.20 * (13) 1.34 _+ 0.29 * (11) 
5-HIAA (ng /mg protein) 1.62 + 0.31 (11) 1.02 + 0.21 (13) 0.95 + 0.22 (1 l) 
Significant differences vs. sham-operated rats: * P < 0.05; number of rats given in parentheses. 
and grafted rats as compared to the sham-operated ones 
(P  < 0.05). The difference between the lesioned and the 
grafted rats was not significant. Due to high variabilities, 
the ANOVA failed to show a significant Group effect for 
either 5-HIAA or NA concentrations (F(2,32)= 2.2 and 
1.0, respectively). Regarding 5-HIAA concentration, there 
was a tendency for this marker to be decreased in lesion- 
only rats as compared to sham-operated rats (P  < 0.10). It 
is also noteworthy that tissue levels of hippocampal NA 
tended to be increased in lesioned rats (P=0.11)  as 
compared to the sham-operated ones, whilst the values 
found in grafted rats were almost identical to those of the 
virtually intact controls (Table 1). 
3.2. [3H]choline accumulation of hippocampal s ices 
Data are shown in Fig. 2. ANOVA of the 'total' 
(specific+unspecific) [3H]choline accumulation values 
showed a significant overall Group effect (F(2,32)= 7.2, 








[ ] Total accumulat lon In plcomoles 
Specific accumulct lon In plcomoleo 
SHAM LESIONED gRAFTED 
GROUPS 
Fig. 2. Accumulation of [3H]choline into hippocampal s ices of sham-op- 
erated, lesioned and grafted rats: 'total' accumulation and values cor- 
rected for 'specificic' (hemicholinium-sensitive) [3H]choline uptake (see 
Section 2). Mean values (±S.E.M., in picomoles [3H]choline) of 11 
sham-operated, 13 lesion-only and 11 grafted rats (data from at least 22 
slices were averaged for each rat prior to statistical analysis). * Signifi- 
cant difference (P  < 0.05) as compared to sham-operated rats; # signifi- 
cant difference (P  < 0.05) as compared to lesion-only rats. 
the values found in both the lesioned and the grafted rats 
as compared to the sham-operated ones (P  < 0.05). In the 
grafted rats, the accumulation values only tended to be 
significantly higher than in the lesioned rats (P = 0.10). 
The proportion of specific [3H]choline accumulation i the 
slices (i.e. of the hemicholinium-3 sensitive part, see Meth- 
ods) was 72.7% (+ 2.5), 50.1% (+6.5) and 56.9 (_+4.1) in 
the sham-operated, the lesioned and the grafted rats, re- 
spectively. ANOVA of the accumulation values corrected 
for specific [3H]choline accumulation still showed a signif- 
icant overall group effect (F(2,32)= 30.3, P < 0.001) 
which is interpreted exactly as for the absolute [3H]choline 
accumulation data, excepted that the difference between 
grafted and lesion-only rats was now significant (P  < 0.05). 
3.3. Euoked overflow of tritium 
The overflow of 3H evoked by the first electrical stimu- 
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Fig. 3. 3H overflow evoked by electrical field stimulation at S 1 in 
hippocampal slices (preincubated with [3H]choline) of sham-operated, 
lesioned and grafted rats, shown as either 'absolute' (in nCi) or 'relative' 
values (in % of t issue-3H). In all experiments only hemicholinium-3 (10 
/~M) was present hroughout superfusion. Mean values (+ S.E.M.) of 11 
sham-operated, 13 lesion-only and 10 grafted rats (data from at least 11 
slices were averaged for each rat prior to statistical analysis). * Signifi- 
cant difference (P  < 0.05) as compared to sham-operated rats; * signifi- 
cant difference (P  < 0.05) as compared to lesion-only rats. 
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3H content of the slices before S t (in the presence of 
hemicholinium-3 alone throughout superfusion), is shown 
in Fig. 3. ANOVA of the absolute amount of 3H overflow 
(in nCi) induced by this stimulation showed a significant 
Group effect (F(2,31) = 25.2, P < 0.001). This effect was 
due to a significant reduction of the overflow of 3H in the 
lesioned as compared to the sham-operated rats ( -65%,  
P < 0.05). The grafts contributed to compensate for this 
lesion-induced reduction: the average value in the grafted 
rats was significantly higher than in the lesioned rats 
(P  < 0.05) and failed to differ significantly from that 
found in the sham-operated rats. ANOVA of the relative 
amounts (% of accumulated [3H]choline) of evoked trans- 
mitter release also showed a significant Group effect 
(F(2,31) = 18.3, P < 0.001) which can be interpreted as 
above. As regards the relative amounts of transmitter 
release, it is noteworthy that half the grafted rats showed 
values (mean = 4.12 _+ 0.49, n = 5) that largely exceeded 
the average value found in the sham-operated rats. 
In the experiments investigating the effects of choliner- 
gic antagonists (atropine, mecamylamine), the AChE in- 
hibitor physostigmine (0.1 /xM) was present throughout 
superfusion in addition to hemicholinium-3, whereas the 
effects of serotonergic drugs were determined in the addi- 
tional presence of the 5-HT 2 receptor antagonist ritanserin 
(1 p~M). The effects of these drugs on the electrically 
evoked [3H]ACh release were assessed by comparing their 
influence on the overflow of 3H at S 1 (Table 2). As evident 
from Table 2, ritanserin did not significantly change the 
evoked overflow of 3H in any surgical treatment group 
(F(1,57) and F(2,57) < 1.0, for the factor Drug and the 
Group × Drug interaction, respectively), whether consid- 
ered in % of accumulated 3H or in nCi. As regards the 
physostigmine effects, the ANOVA showed overall Group 
(F(2,41) = 6.3 (%) and 9.3 (nCi), P < 0.01) and Drug 
(F(1,41) = 23.1 (%) and 23.8 (nCi), P < 0.001) effects. 
The Drug effect was due to a significant physostigmine-in- 
duced reduction of the evoked [3H]ACh release in the 
three groups (P  < 0.01). The Group × Drug interactions 
tended to be significant (F(2,41) = 2.7 (%) and 2.6 (nCi), 
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Fig. 4. Effects of atropine or mecamylamine on the electrically-evoked 
[3H] overflow (expressed as the ratio $2 /S  1) in hippocampal slices 
(preincubated with [3 H]choline) of sham-operated, lesion-only and grafted 
rats. Atropine or mecamylamine were added to the medium from 16 min 
before S 2 onwards. Mean values (+ S.E.M. in picomoles of [3H]choline) 
of 5 sham-operated, 5 lesion-only and 5 grafted rats (data from at least 3 
slices were averaged for each rat and each drug condition prior to 
statistical analysis). For the overflow evoked at S 1, see Table 2. * Sig- 
nificant difference (P < 0.05) as compared to the respective control value 
within each group; # significant difference (P < 0.05) as compared to the 
values found with the slices of sham-operated rats exposed to atropine. 
physostigmine that were significantly less pronounced in 
sham-operated (56 + 4% inhibition) and lesioned rats (46 
+ 6% inhibition) as compared to the grafted rats (70 + 6% 
inhibition). 
3.4. Effects of atropine and mecamylamine 
These experiments were performed in the presence of 
physostigmine (0.1 /xM, see above) in order to increase 
the concentration of the endogenous agonist ACh. The data 
expressed as $2/S 1 ratios are shown in Fig. 4. The Group 
(sham, lesion, graft)× Drug (control, atropine 1 ~M, 
Table 2 
Electrically evoked overflow of 3H at S 1 in the presence of various drugs present throughout superfusion 
Drugs present throughout superfusion Sham Lesioned Grafted 
Hemicholinium-3 % 
nCi 
Hemicholinium-3 + ritanserin % 
nCi 
Hemicholinium-3 + physostigmine % 
nCi 
2.39 + 0.15 (10) 1.02 + 0.1 # (12) 2.76 + 0.5 § (10) 
2.19 _+ 0.1 0.69 _+ 0.1 # 2.15 _+ 0.4 § 
2.67 + 0.2 (9) 1.15 + 0.1 # (12) 2.34 + 0.4 § (10) 
2.40 + 0.07 0.72 + 0.1 # 1.82 + 0.3 § 
1.06 _ 0.06 * (5) 0.55 + 0.03 * # (5) 0.82 + 0.07 * ~§ (5) 
0.98 _+ 0.03 * 0.31 + 0.06 * # 0.58 _+ 0.01 * #§ 
Data are given in percentage of tissue -3H (%) and in nCi. Slices of the dorsal hippocampus from rats with different surgical treatments were preincubated 
with [3H]choline and superfused (as described in Section 2) either in the presence of hemicholinium-3 (10 ~M) alone, or in the additional presence of 
ritanserin (1 /zM) or physostigmine (0.1 /zM). Electrical stimulation was performed after 57 min of superfusion. Significant differences (in each surgical 
treatment group) as compared to the presence of hemicholinium-3 alone: * P < 0.05; as compared to sham-operated rats: # P < 0.05; as compared to 
lesioned rats: § P < 0.05; number of rats given in parentheses. 
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mecamylamine 10 /~M) ANOVA showed significant ef- 
fects of the factors Group (F(2,12) = 43.8, P < 0.001) and 
Drug (F (2 ,24)= 354.1, P < 0.001), as well as a signifi- 
cant Group × Drug interaction (F(4,24) = 33.6, P < 
0.001). In all three groups, the application of atropine 
resulted in a significant increase of [3H]ACh release (P  < 
0.05), whilst mecamylamine had no significant effect. The 
atropine-induced increase was significantly more pro- 
nounced in the sham-operated rats as compared to both the 
lesioned and the grafted ones (P  < 0.05); the difference 
between the average values found in the two latter groups 
was not significant. 
3.5. Effects of oxotremorine 
The data were first expressed as either $2 /S  1 or $3 /S  1 
ratios of the values found after application of different 
doses of oxotremorine and subsequently converted into a 
percentage of the appropriate control ratio ($2 /S  ~ and 
$3 /S  1 without application of oxotremorine). These con- 
verted values were analysed using a Group × Dose (0.01- 
10 ~M dose range) ANOVA (Fig. 5). The analysis howed 
a significant Group effect (F (2 ,14)= 7.1, P < 0.01), as 
well as a significant effect of the Dose (F(3,42) = 541.8, 
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Fig. 5. Effects of oxotremorine on the evoked 3H overflow in hippocam- 
pal slices (preincubated with [3H]choline) of sham-operated, lesion-only 
and grafted rats. The effects of various concentrations of oxotremorine on 
the evoked 3H overflow ($2/S  1 or $3/S  1 ratios) are expressed as a 
percentage of the respective control ratios (no oxotremorine, see text). 
The superfusion medium contained only hemicholinium-3 (10 #M) 
throughout superfusion; oxotremorine was added to the medium (in the 
concentrations indicated on the abscissa) from 16 min before $2, or $3, 
respectively, onwards. For the overflow evoked at S 1, see Table 2 and 
Fig. 3. Mean values (+ S.E.M.) of 5 sham-operated, 7 lesion-only and 5 
grafted rats (data from at least 4 slices were averaged for each rat and 
each drug condition prior to statistical analysis). * denotes ignificant 
(P < 0.05) oxotremorine-induced r uction in all three groups as com- 
pared to the respective control values (no oxotremorine); ~' denotes 
significant (P < 0.05) differences as compared to the values found with 
the slices of the sham-operated rats exposed to the same concentration f
oxotremorine. 
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Fig. 6. Effects of serotonergic drugs on the evoked 3H overflow (ex- 
pressed as the ratio S 2/S 1) in hippocampal slices (preincubated with 
[3 H]choline) of sham-operated, l sion-only and grafted rats. In addition to 
hemicholinium (10 /xM), the medium contained ritanserin (1 /~M) 
throughout superfusion. Methiothepin, 2-methyl-serotonin or CP 93129 
were added from 16 min before before S 2 onwards. For the overflows 
evoked at $1, see Table 2. Mean values (+ S.E.M.) of 4 sham-operated, 5 
lesioned and 5 grafted rats (data from at least 3 slices were averaged for 
each rat and each drug condition prior to statistical nalysis). * denotes 
significant differences (P < 0.05) as compared to the respective control 
value within each group. 
P < 0.001). There was no significant interaction between 
these two factors. Compared to the 100% control value in 
each group, oxotremorine was found to induce a signifi- 
cant reduction of the evoked [3H]ACh release at the doses 
of 0.1, 1 and 10 /xM (P< 0.05), the inhibition of the 
release being of about 20% at 0.1 /~M and of slightly more 
than 80% at 10/zM.  At the doses of 0.1, 1 and 10/zM,  we 
found the evoked release to be significantly higher in 
lesioned rats as compared to the respective values found in 
sham-operated rats (P  < 0.05). The grafted rats showed 
values intermediate between those of sham-operated and 
lesioned rats. The difference between grafted and lesioned 
rats was significant only at the dose of 0.1 /xM (P  < 0.05). 
3.6. Effects of 5-HT receptor agonists and antagonists 
These experiments were performed in the presence of 
the 5-HT 2 antagonist ritanserin (1 /xM) throughout super- 
fusion. In the presence of the 5-HTIA agonist 8-OH-DPAT 
at S 2 the evoked 3H overflow from the slices was not 
significantly affected (results not illustrated; $2 /S  1 ratios 
were 1.06 + 0.07 in sham rats, 1.16 + 0.10 in lesioned rats 
and 1.0 + 0.05 in grafted rats; control ratios were 1.11 + 
0.07, 0.98 ___ 0.08 and 0.98 + 0.10, respectively). Data 
($2 /S  1 ratios) concerning the other serotonergic drugs are 
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Fig. 7. Effects of CP 93128 on the evoked 3H overflow in hippocampal 
slices (preincubated with [3H]choline) of sham-operated, lesion-only and 
grafted rats. The effects of various concentrations of CP 93128 on the 
evoked 3H overflow (S 2 /S  1 or 83/51 ratios) are expressed as a 
percentage of the respective control ratios (no CP 93128, see text). The 
superfusion medium contained hemicholinium-3 (10 /xM) and ritanserin 
(1 /LM) throughout superfusion; CP 93128 was added to the medium (in 
the concentrations indicated on the abscissa) from 16 min before S 2, or 
$3, respectively, onwards. For the overflow evoked at $1, see Table 2. 
Mean values (+ S.E.M.) of 5 sham-operated, 7 lesion-only or 5 grafted 
rats (data from at least 4 slices were averaged for each rat and each drug 
condition prior to statistical analysis). * denotes ignificant (P  < 0.05) 
CP 93128-induced reductions in all three groups as compared to the 
respective control values (no CP 93128); # denotes ignificant (P  < 0.05) 
differences as compared to the values found with the slices of the 
sham-operated rats exposed to the same concentration of CP 93128. 
depicted in Fig. 6. The Group × Drug ANOVA showed no 
significant Group effect, but both the Drug effect and the 
Group × Drug interaction were significant (F(3,33) = 23.9, 
P < 0.001; F(6,33) = 3.8, P < 0.01). Whilst methiothepin 
and 2-methyl-serotonin failed to produce a significant 
modification of [3H]ACh release, CP 93129 significantly 
inhibited this release by 31% in sham-operated rats, 26% 
in lesioned rats and only 15% in grafted rats. The signifi- 
cant interaction can be explained by an inhibitory effect of 
CP 93129 which was more pronounced in both the sham- 
operated and the lesion-only rats than in the grafted ones. 
These inhibitory effects of CP 93129 on the evoked release 
of [3H]ACh were also found when methiothepin (10 /zM) 
was co-applied with the 5-HT1B agonist, although this 
inhibition was now of similar amplitude in the three 
experimental groups (approx. -30%; data not shown). 
Methiothepin had no proper effect. 
The experiment investigating the dose-response r la- 
tionship between CP 93129 and [3H]ACh release was 
performed according to a protocol similar to that in which 
several doses of oxotremorine were applied (see above). 
Data are presented in Fig. 7. The ANOVA showed signifi- 
cant Group (F(2,14) = 6.1, P < 0.05) and Dose (F(3,42) 
= 87.2, P < 0.001) effects, as well as a significant interac- 
tion between these two factors (F(6,42) = 4.1, P < 0.01). 
At the dose of 0.1 p,M, the inhibition was significant only 
in sham-operated rats (P  < 0.05). At higher doses, the 
inhibition was significant in all groups, although there was 
a marked between-group difference in the amplitude of the 
inhibition. In the grafted rats, the inhibition induced by 10 
/zM and 100 /xM of CP 93129 was significantly less 
pronounced ( -  22,6% and -22.8%, respectively) than in 
either sham-operated ( -33% and -39.6%, respectively) 
or lesioned rats ( -33.6% and -36.9%, respectively). 
4. Discussion 
4.1. General observations on neurochemical parameters 
In line with our previous findings [26,27], the present 
experiment confirms that electrolytic fimbria-fomix lesions 
induce, among other deficits, a severe cholinergic denerva- 
tion of the hippocampus. This denervation was demon- 
strated by significant decreases in hippocampal ACHE- 
positivity, ChAT activity, accumulation of [3H]choline in 
hippocampal s ices, and electrically-evoked 3H overflow in 
hippocampal slices preincubated with [3H]choline. Since 
electrically-evoked overflow of 3H from brain slices prein- 
cubated with [3H]choline has been shown many times 
(e.g., [24]) to reflect action potential-induced, exocytotic 
release of ACh, only the expression 'evoked ACh (or 
[3H]ACh) release' will be used hereafter. 
As regards the graft-induced effects, we also confirm 
that grafts rich in cholinergic neurons are able to attenuate 
the cholinergic deficit due to the lesions. The grafts actu- 
ally provided the hippocampus with a new AChE-positive 
innervation, increased (but did not normalize) the accumu- 
lation of [3H]choline in hippocampal slices, and normal- 
ized the evoked release of [3H]ACh in absence of any drug 
application. If one excepts the failure of our grafts to 
significantly increase the hippocampal ChAT activity, all 
these findings are in good agreement with many other 
reports [13,14,18,22,27,29,30,52]. 
A methodological explanation to the fact that the grafts 
failed to significantly affect the ChAT activity in the 
denervated hippocampus can be proposed. Actually, in a 
previous experiment by Jeltsch et al. [27], we found elec- 
trolytic fimbria-fornix lesions to reduce ChAT activity by 
about 70% in the dorsal part of the hippocampus and by 
only about 40% in the ventral part. Grafts rich in choliner- 
gic neurons placed into the dorsal hippocampus were 
found to significantly increase ChAT activity in the dorsal 
hippocampus, but they failed to exert significant effects in 
its ventral part, probably because the graft-derived fibers 
failed to grow into this distal region. In our present 
experiment, he activity of ChAT was assessed on ho- 
mogenates prepared from the hippocampal tissue pieces 
next to those used in the superfusion experiments (part of 
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ventral region). Therefore, the detection of significant 
graft-induced effects could simply not be expected in the 
material that we used to prepare the homogenates because 
of a too ventral neuroanatomical origin of the slices that 
were homogenized. These samples, nevertheless, allowed 
to detect lesion-induced effects, a finding which is consis- 
tent with our previous report [27]. 
Also, HPLC data on tissue levels of 5-HT, 5-HIAA and 
noradrenaline are in agreement with our previous observa- 
tions on more ventral parts of the hippocampal formation 
[14,26]: serotonin concentration was significantly dimin- 
ished in both lesion-only and grafted rats, whereas nor- 
adrenaline levels tended to be increased in the former but 
were close to normal in the latter group. This confirms our 
previous reports [9,13] showing that septal grafts do not 
affect serotonergic parameters and that graft-derived 
cholinergic reinnervation of the hippocampus may prevent 
a lasting increase of hippocampal noradrenaline concentra- 
tion induced by septohippocampal lesions. Although we 
did not find the lesion-induced increase of noradrenaline 
concentration to be significant in our present experiment, 
this increase was found to be significant in two former 
experiments [9,14] in which the lesions of the fimbria-for- 
nix were larger (aspiration of the infracallosal and supra- 
callosal pathways) than in the present study (electrolysis of 
only the infracallosal pathways). The denervation-induced 
increase in hippocampal noradrenaline l vels may be due 
to a sprouting response of (peripheral) sympathetic neu- 
rons innervating cerebral microvessels [16]. 
4.2. Modulation of ACh release 
ence of the 5-HT 2 receptor antagonist ritanserin, since it 
has been shown [2] that the 5-HT 3 agonist 2-methyl-sero- 
tonin inhibited ACh release in cortical slices only in its 
presence. Interestingly, the nonselective 5-HT1/5-HT 2 re- 
ceptor antagonist methiothepin was without any facilita- 
tory effect even in sham-operated rats. This observation 
indicates that under the present experimental conditions, an 
inhibitory tone of endogenously released 5-HT was not 
detectable. Recently, several studies using the in vivo 
microdialysis technique suggested [3,25,55] that hippocam- 
pal ACh release might also involve modulatory 5-HT1A 
receptors. Since 8-OH-DPAT showed no effect on ACh 
release from brain slices in vitro (present report and [39]), 
it must be concluded that 5-HT1A receptors modulating 
ACh release in vivo are located on neurons of polysynaptic 
loops rather than on cholinergic axon terminals them- 
selves. In conclusion, all observations of the present study 
are in line with previous reports upon pharmacological 
properties of 5-HT receptors on cholinergic terminals in 
the intact rat hippocampus (e.g., [6,7,38,39]). 
In addition to previous experiments that have demon- 
strated the activity of cholinergic neurons grafted into the 
denervated hippocampus to be regulated by host afferents 
(e.g., [33,41,42]), our results how that the release capabili- 
ties of such neurons may also be regulated by mechanisms 
involving muscarinic autoreceptors and serotonergic het- 
eroreceptors of the 5-HTIB type. A major contribution of 
the present experiment is the demonstration that both the 
muscarinic autoreceptors and the serotonergic heterorecep- 
tors show a sensitivity which may depend upon the surgi- 
cal treatment to which the rats have been submitted. 
In our three experimental groups, we have determined 
the efficacy of two types of mechanisms that may exert a 
presynaptic modulation of ACh release in the hippocam- 
pus. One of these mechanisms involves an inhibitory mus- 
carinic autoreceptor which - in the rat hippocampus - 
probably belongs to the M2 type [46,47], although McKin- 
ney et al. [40] have provided some evidence that septohip- 
pocampal terminals in the rat might possess receptors of 
the M4 type. In this regard, it is noteworthy that Wael- 
broeck et al. [53] assigned 22% of  the N-[3H]methyl - 
scopolamine binding sites in the rat hippocampus to the 
M4 subtype and 12% to the M2 type, respectively. Our 
experimental design did not allow to address the question 
of which subtype of receptors is responsible for the ob- 
served effects on evoked [3H]ACh release. 
The other presynaptic inhibitory mechanism involves a 
serotonergic heteroreceptor which is presumably of the 
5-HT~B type, a possibility consistent with our findings 
showing that neither 8-OH-DPAT (a selective 5-HT1A 
agonist), nor 2-methyl-serotonin (a selective 5-HT 3 ago- 
nist) produced any significant effect on evoked [3H]ACh 
release, whereas CP 93129 (a selective 5-HTIB agonist 
(see [36]) did significantly and dose-dependently attenuate 
this release. Our experiments were performed in the pres- 
4.3. SensitiL, ity of muscarinic autoreceptors 
Before discussing this point, it is important to recall that 
ACh release xperiments realized on hippocampal s ices of 
sham-operated (or intact) rats differ in one important as- 
pect from those performed on slices prepared from lesion- 
only or grafted rats. Indeed, in material from intact rats, 
the targets of the superfused cholinergic drugs mainly 
consist of the receptors located on the cholinergic nerve 
terminals (i.e. presynaptic receptors). Conversely, in slices 
from grafted rats, somatodendritic receptors located on the 
grafted cholinergic neurons are additional targets that may 
be involved in the regulation of cholinergic activity and 
ACh release. 
As regards the modulation of ACh release via mus- 
carinic autoreceptors, several findings of the present study 
deserve discussion. First, in hippocampal s ices of grafted 
rats, the absolute amount of evoked ACh release (values in 
nCi) did not differ from that found in sham-operated rats; 
in half of the grafted rats, the relative amount (in % of 
tissue tritium) of evoked ACh release was even largely 
higher than in the sham group, an observation suggesting 
that, in this subpopulation of grafted rats, a higher amount 
of ACh per stimulus and per nerve terminal was released. 
J.-C. Cassel et al. / Brain Research 704 (1995) 153-166 163 
That not all grafted rats have presented such an increase 
might be due to some fluctuations in the quality of the 
transplant's integration. Unfortunately, our experimental 
protocol did not allow us to perform histological verifica- 
tions of this quality in the rats used for the superfusion 
experiments as all slices prepared from the hippocampal 
tissue pieces were necessary because of statistical con- 
straints. Second, the effect of the AChE inhibitor 
physostigmine was more pronounced in slices from grafted 
rats as compared to both lesion-only and sham-operated 
rats. Since physostigmine (as an indirect cholinomimetic 
drug) increases the concentration of ACh in the vicinity of 
the axon terminals ('biophase concentration of ACh'), i.e. 
near the inhibitory muscarinic autoreceptors, this finding 
again supports the notion of an increased ACh release per 
stimulus. Third, the facilitatory effect of atropine (in the 
presence of physostigmine) on the evoked ACh release 
was significantly weaker in slices from grafted rats as 
compared to those from sham-operated rats. Although the 
latter finding could also be explained by the increased 
biophase concentration of ACh (which competes with at- 
ropine at the receptor), an alternative possibility would be 
that the muscarinic autoreceptor in the hippocampus of 
grafted and lesioned rats underwent a downregulation, 
leading to a decreased sensitivity towards atropine and 
thereby to an increased amount of evoked ACh release per 
stimulus and nerve terminal. 
However, in the experiments using application of ox- 
otremorine (in the absence of physostigmine), such a 
downregulation was found to be significant only in the 
lesioned rats. In these rats, the oxotremorine-induced de-
crease of [3H]ACh release was actually less pronounced 
than in the intact control rats. The values found in the 
grafted rats were intermediate between those found in the 
groups of sham-operated and lesioned rats but differed 
significantly from neither. At present, the reason for which 
we could not demonstrate a diminished sensitivity of the 
muscarinic autoreceptor towards oxotremorine in grafted 
rats is unclear. One possible explanation is that the exoge- 
nous agonist oxotremorine may have sites of action located 
on grafted neurons which do not exist on the cholinergic 
terminals of sham-operated rats. In grafted rats, these sites 
might be somatodendritic muscarinic receptors (see above). 
In the lesioned rats, the downregulation of muscarinic 
autoreceptors can be considered as an adaptive change 
occurring in the terminals of the cholinergic neurons pared 
by the lesion procedure. This adaptive change is probably 
based on an attenuation of the autoinhibitory processes at 
the level of the cholinergic terminals that survived the 
lesion procedure, thereby contributing to increased cholin- 
ergic function in the preserved neurons. Such a downregu- 
lation of the autoreceptors might be a direct consequence 
of an increased turnover in the undamaged cholinergic 
neurons. This possibility is in agreement with the report of 
Lapchak et al. [32] who showed that after a partial lesion 
of the fimbria-fornix pathways, the undamaged cholinergic 
neurons of the septohippocampal system upregulate their 
capacity to synthesize and store ACh. That these neurons 
might also increase their capacity to release greater amounts 
of stored ACh is indirectly suggested by the presence of 
downregulated muscarinic autoreceptors on the cholinergic 
terminals, as suggested by our present results. 
Recently, Potter and Nitta [45] reported that after 
AF64A-induced lesions of the cholinergic hippocampal 
afferents, the remaining cholinergic terminals completely 
lost their ability to regulate the release of ACh via mus- 
carinic receptors, whilst the regulatory mechanisms involv- 
ing facilitatory nicotinic receptors were not only con- 
served, but even exacerbated. In our lesioned rats, we did 
not observe such an exacerbation, a failure that might 
probably be explained by the differences in the respective 
lesion methods (electrolysis of the fimbria and the fornix 
v.s i.c.v, injections of AF64A), stimulation characteristics 
(360 pulses, 3 Hz, 4 V vs. 240 pulses, 2 Hz, 30 V), 
incubation procedures ( lices not stimulated uring incuba- 
tion vs. slices stimulated) or drug application protocols 
(physostigmine-containing buffer throughout the superfu- 
sion experiment vs. no physostigmine throughout), and 
other technical differences. Further experiments are cer- 
tainly required to address this particular question in more 
detail. 
Regarding previous experiments, one could expect the 
grafts rich in cholinergic neurons to attenuate or even to 
counterbalance some of the neurochemical or pharmaco- 
logical alterations induced by the lesions (e.g., 
[13,14,18,22,27,29,30,52]). In our present experiment, such 
expectations were verified on parameters such as 
[3H]choline accumulation i the slices or [3H]ACh release 
in absence of any drug application (see above). It is 
noteworthy, however, that in some respects, a muscarinic 
downregulation similar to that found in the lesioned rats 
was also observed on the terminals of the grafted neurons, 
at least under the condition of atropine application. This 
finding may appear as somewhat sfirprising regarding pre- 
vious reports howing that the lesion-induced alterations of 
muscarinic sensitivity in the hippocampus may be counter- 
balanced by grafts rich in cholinergic neurons (e.g., 
[18,29,54]). However, as discussed in these reports, the 
lesion-and graft-induced effects did probably involve 
muscarinic receptors located at a postsynaptic level. At the 
presynaptic level, our findings may suggest that the grafted 
cholinergic neurons have developed some abnormal (or 
failed to develop normal) pharmacological characteristics 
as regards the muscarinic autoinhibitory control mecha- 
nisms of ACh release. The modification of the pharmaco- 
logical properties found at the terminals of the grafted 
cholinergic neurons does probably reflect a functional 
facilitation in the grafted cholinergic neurons, in particular 
as regards the release of ACh. 
Beside the findings reported by Dawson et al. [18] or by 
Joyce et al. [29], our present results suggest that some 
modifications in the sensitivity of muscarinic receptors 
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may also occur at the presynaptic level of cholinergic 
neurons which have survived the lesion or which have 
been grafted into the hippocampus. 
4.4. Sensitivity of serotonergic heteroreceptors 
As was the case for the muscarinic autoreceptors, we 
also found the sensitivity of the 5-HT1B heteroreceptors to 
depend upon the surgical treatment of the rats. Actually, 
the evoked release of [3H]ACh in presence of 10 or 100 
/xM of CP 93129 was reduced to a level which was 
significantly lower in both the sham-operated and the 
lesioned rats (approx. -33% and -38%,  respectively) as 
compared to the grafted ones (approx. -23%).  This differ- 
ence between the grafted rats and the rats from the two 
other groups suggests that the 5-HT1B receptors located on 
the terminals of the grafted cholinergic neurons have been 
downregulated or have failed to express normal functional 
characteristics as regards the serotonin-mediated mecha- 
nisms involved in the presynaptic regulation of ACh re- 
lease. In addition to the muscarinic dowregulation that was 
found in our grafted neurons, the abnormality in the sensi- 
tivity of 5-HT~B receptors might be considered as another 
type of adaptive change which, at the terminals of the 
grafted cholinergic neurons, might be considered as benefi- 
cial as it may contribute to increase the graft-derived 
cholinergic function in the hippocampus. 
A theoretical explanation for this 5-HT1B downregula- 
tion in the grafted cholinergic neurons would be that the 
grafts contained serotonergic neurons that tonically re- 
leased 5-HT. However, a previous experiment has demon- 
strated that intrahippocampal septal tissue grafts prepared 
according to the method used in the present experiment did 
not alter the lesion-induced effects on serotonergic markers 
in the hippocampus [27], an observation suggesting that 
these grafts were devoid of serotonergic neurons. In the 
present experiment, our HPLC data confirmed these obser- 
vations. In previous experiments [26,27], we repeatedly 
found lesions identical to those performed in the present 
experiment to severely reduce some serotonergic markers 
in the dorsal hippocampus (i.e., synaptosomal serotonin 
uptake, serotonin and 5-hydroxyindoleacetic acid concen- 
trations) and to increase the ratio of 5-hydroxyindoleacetic 
acid and serotonin concentrations. The latter modification 
indicates that the serotonin turnover has been upregulated 
in the neurons spared by the lesions, an upregulation by 
which serotonergic fibers tend to compensate for the re- 
duced serotonergic innervation of the hippocampus (e.g., 
[1,14,17]). Theoretically, it is possible to consider that such 
an upregulation of the turnover might account for a down- 
regulated sensitivity of the serotonergic receptors in the 
close vicinity of the spared serotonergic terminals. Never- 
theless, if such an explanation would be appropriate to 
account for our present findings in the grafted cholinergic 
neurons, a 5-HT~ downregulation should also have been 
observed in the undamaged cholinergic neurons of the 
lesion-only rats. As this was not the case, one may be 
tempted to propose another (speculative) xplanation based 
on consideration of abnormal maturation of some phar- 
macological characteristics of the cholinergic terminals 
originating in the grafted tissue. 
Actually, the cholinergic neurons which were grafted at 
a stage of complete immaturity may have failed to express 
a completely normal phenotypic set of pharmacological 
characteristics over the 6.5-8 months long postgrafting 
survival time. In other words, it is possible that in a 
serotonin-depleted cellular environment, thus in absence of 
a normal evel of serotonergic nputs, the grafted choliner- 
gic neurons failed to express a 5-HTIB sensitivity compa- 
rable to that found in the hippocampus of intact rats. This 
highly speculative hypothesis would certainly deserve fur- 
ther experimentation. For instance, it might be interesting 
to compare the sensitivity of 5-HTIB receptors when 
cholinergic neurons are implanted with a procedure identi- 
cal to that used in our present experiment (single grafts), or 
when these neurons are implanted in combination with a 
preparation rich in serotonergic neurons (co-grafts of two 
different neurochemical populations of cells), the latter 
being able to provide the denervated hippocampus with a 
new serotonergic nnervation (e.g., [27,41]). 
4.5. Conclusions 
The results of our present experiment confirm that 
grafts of basal forebrain cholinergic neurons provide the 
denervated hippocampus with new cholinergic terminals 
that are, in some respects, functional as they are able to 
release ACh. These results also demonstrate hat the grafted 
cholinergic neurons express some of the pharmacological 
characteristics found on cholinergic terminals in the hip- 
pocampus of normal rats. In particular, the terminals of 
these neurons possess functional muscarinic autoreceptors 
and 5-HT1B heteroreceptors, which both contribute to re- 
duce the release of ACh when they are activated. How- 
ever, the functional properties of these receptors were not 
completely normal, as both showed a lower sensitivity than 
that found in normal rats. Both types of downregulations, 
however, may contribute to increase cholinergic function 
in the grafted tissue by reducing the inhibitory tonus that 
ACh and serotonin exert at the level of the cholinergic 
terminals. 
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